-
European Commission Approves Merck’s KEYTRUDA® Plus Chemotherapy for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
28 Mar 2024 22:07 GMT
… advances for patients with metastatic lung cancer, lung cancer continues to be the … resectable non-small cell lung cancer at high risk of … in earlier stages of lung cancer,” said Marjorie Green, … drive earlier diagnoses of lung cancer, an urgent need.”
…
-
Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung…
28 Mar 2024 20:41 GMT
… locally advanced or metastatic KRASG12C-mutated lung cancer. FDA approval … patients with KRASG12C-mutated lung cancer.”
The company will … advanced non-small cell lung cancer and disease progression … including non-small cell lung cancer and colorectal cancer.
…
-
Hutchmed lung cancer treatment accepted for review in China
28 Mar 2024 11:25 GMT
… with locally advanced or metastatic non-small cell lung cancer. It had previously … of the world's lung cancer patients are in China,…
-
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
28 Mar 2024 11:00 GMT
… for patients with metastatic lung cancer, lung cancer continues to … earlier stages of lung cancer,” said Marjorie … cycles.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer …
-
Campaigner urges government for tobacco law change after dad dies of lung cancer
28 Mar 2024 09:32 GMT
… and Kenneth was diagnosed with metastatic lung cancer in 2001 and he died …
-
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
28 Mar 2024 18:17 GMT
… among patients with metastatic melanoma and non-small cell lung cancer. These data … , sex, performance status, International Metastatic RCC Database Consortium risk score … analogous studies in melanoma and lung cancer. Additional prospective randomized trials …
-
Novocure’s TTFields device slows metastasis in NSCLC
28 Mar 2024 17:34 GMT
… brain metastasis in patients with non-small cell lung cancer (NSCLC … unresectable, locally advanced, or metastatic, malignant pleural mesothelioma.
… NSCLC along with brain metastasis. The patients received … progression for brain metastasis of 21.9 months …
-
Novocure Gets Phase III Win in Patients with Brain Metastases from Lung Cancer
27 Mar 2024 18:41 GMT
… with brain metastases from non-small cell lung cancer after … adult patients with brain metastases treated with TTFields … 10 brain metastases from non-small cell lung cancer (NSCLC), … with brain metastases from non-small cell lung cancer are frequently …
-
Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows
27 Mar 2024 14:57 GMT
… 1-10 brain metastases from non-small cell lung cancer (NSCLC) following stereotactic … supportive care alone for brain metastasis.
TTFields therapy was well-tolerated … therapies for non-small cell lung cancer, following progression on or after …
-
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
27 Mar 2024 13:45 GMT
… -10 brain metastases from non-small cell lung cancer (NSCLC) … intracranial progression.
About Brain Metastases from NSCLC in China … the treatment of brain metastases from lung cancer (2021 edition). Chinese … for patients with brain metastases from NSCLC. These …